Physician

Sandeep Jain, MBBS, MRCP

According to 2025 Medicare claims, Sandeep Jain, MBBS, MRCP (NPI: 1679746481) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Dakota, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55337-6743. Jain is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 304 traditional Medicare patients, billed 101,548 HCPCS/CPT codes, and received $2,122,852 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,218 prescription claims across 176 beneficiaries totaling $1,974,320 in drug costs, led by Erleada (Apalutamide). DME data shows 26 claims. Open Payments data shows 4 records totaling $8,187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,778 to $2,122,852. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $320,470 and ending at $1,974,320. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $0 and ending at $2,319.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	79	304	$16,778
2016	223	1,359	$56,117
2017	228	672	$40,752
2018	249	691	$41,869
2019	357	1,063	$66,317
2020	370	75,583	$1,397,465
2021	336	138,214	$2,399,747
2022	321	114,580	$2,013,547
2023	308	111,362	$2,101,194
2024	304	101,548	$2,122,852

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	287	$320,470
2016	198	1,241	$1,688,661
2017	222	1,329	$2,403,614
2018	226	1,259	$2,180,729
2019	250	1,701	$2,799,029
2020	230	963	$1,140,809
2021	110	555	$391,798
2022	119	916	$1,836,733
2023	170	1,104	$1,800,551
2024	176	1,218	$1,974,320

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	35	$11,994
2018	N/R	11	$207
2019	N/R	59	$4,101
2020	N/R	23	$1,254
2021	N/R	N/R	N/R
2022	N/R	23	$3,195
2023	N/R	24	$1,212
2024	N/R	26	$1,360

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	74	222	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	96	274	$102
80053	Blood test, comprehensive group of blood chemicals	131	406	$10
36415	Insertion of needle into vein for collection of blood sample	128	403	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	134	492	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	22	660	$302,337
Ibrance	Palbociclib	18	504	$287,440
Revlimid	Lenalidomide	24	646	$284,517
Calquence	Acalabrutinib Maleate	12	360	$129,120
Venclexta	Venetoclax	29	808	$94,876

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$896
E1392	Portable oxygen concentrator, rental	Y	N/R	13	$464

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$187	Intera Oncology, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$8,000	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sandeep Jain, MBBS, MRCP?

Tedicare shows public-source Medicare data for Sandeep Jain, MBBS, MRCP (NPI 1679746481), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sandeep Jain, MBBS, MRCP have ACO affiliation data?

Sandeep Jain, MBBS, MRCP is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sandeep Jain, MBBS, MRCP?

Sandeep Jain, MBBS, MRCP is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Sandeep Jain, MBBS, MRCP have Open Payments data?

Sandeep Jain, MBBS, MRCP has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.